Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

6701.T JP Equity

NEC CorporationInformation Technology · FY ends Mar 31
JPY 4,786.00
-382.00 (-7.39%)
JPY · as of 2026-08-17 · marketstack
1 registered study · 0 active

Studies where 6701.T is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

1 interventional

Held by 0 tracked-famous managers · government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® EndoscopyNCT05611151Adenomas per Colonoscopy (APC)Randomized · Open-label · DiagnosticNot applicableCompletedDiagnostic test: Computer Aided Detection (CADe)Colorectal Cancer, Adenoma Colon, Polyp of Colon8302024-09-10actual2024-09-19

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19